Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

Metabotropic glutamate (mGlu) receptors are a large, heterogeneous family of G-protein coupled receptors, which modulate excitatory synaptic transmission through various transduction pathways. Evidence is now accumulating that individual mGlu-receptor subtypes mediate distinct, facilitatory (group I subtypes) or inhibitory (group II and group III subtypes), actions on neurodegenerative processes. Drugs interacting with mGlu receptors are expected to influence both the induction and progression of neuronal degeneration without hampering the efficiency of fast excitatory synaptic transmission. For these reasons, mGlu receptors can be considered as promising drug targets in the experimental therapy of acute or chronic neurodegenerative diseases.

[1]  P. Roberts.  Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): Phenylglycine derivatives and other selective antagonists—an update , 1995, Neuropharmacology.

[2]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[3]  S. Nakanishi.  Molecular diversity of glutamate receptors and implications for brain function. , 1992, Science.

[4]  D A Greenberg,et al.  Glutamate and Parkinson's disease , 1994, Annals of neurology.

[5]  Joseph B. Martin,et al.  Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid , 1986, Nature.

[6]  D. Choi,et al.  Neurotoxicity ofβ-N-methylamino-l-alanine (BMAA) andβ-N-oxalylamino-l-alamine (BOAA) on cultured cortical neurons , 1989, Brain Research.

[7]  F. Nicoletti,et al.  Stimulation of Inositol Phospholipid Hydrolysis by Excitatory Amino Acids Is Enhanced in Brain Slices from Vulnerable Regions after Transient Global Ischemia , 1989, Journal of neurochemistry.

[8]  B. Yankner,et al.  Inhibition of β‐Amyloid Production by Activation of Protein Kinase C , 1993 .

[9]  J. Olney,et al.  Excitotoxicity and the NMDA receptor - still lethal after eight years , 1995, Trends in Neurosciences.

[10]  M. Johnston,et al.  Perinatal Hypoxic‐Ischemic Brain Injury Enhances Quisqualic Acid‐Stimulated Phosphoinositide Turnover , 1988, Journal of neurochemistry.

[11]  D. Choi,et al.  The inhibitory mGluR agonist, s-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death , 1995, Neuropharmacology.

[12]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  P. Somogyi,et al.  Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization , 1994, Neuroscience.

[14]  G. Westbrook,et al.  L-AP4 inhibits calcium currents and synaptic transmission via a G- protein-coupled glutamate receptor , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  P. Nunn,et al.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.

[16]  H. Shinozaki,et al.  Novel agonists for metabotropic glutamate receptors: trans- and cis-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (trans- and cis-MCG-I) , 1995, Neuropharmacology.

[17]  H. Shinozaki,et al.  A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord , 1993, British journal of pharmacology.

[18]  K. Reymann,et al.  The metabotropic glutamate receptor antagonist ( + )-α-methyl-4-carboxyphenylglycine protects hippocampal CA1 neurons of the rat from in vitro hypoxia/hypoglycemia , 1994, Neuropharmacology.

[19]  H. Shinozaki,et al.  Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic Degeneration , 1995, The European journal of neuroscience.

[20]  R. Lefkowitz,et al.  Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway , 1995, Nature.

[21]  S. Glaum,et al.  Acute Regulation of Synaptic Transmission by Metabotropic Glutamate Receptors , 1994 .

[22]  P. Conn,et al.  Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  J. Olney,et al.  Blockade of the second messenger functions of the glutamate metabotropic receptor is associated with degenerative changes in the retina and brain of immature rodents , 1995, Neuropharmacology.

[24]  J. Mcdonald,et al.  The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury. , 1992, European journal of pharmacology.

[25]  P. Suzdak,et al.  A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line , 1993, Brain Research.

[26]  I. Black,et al.  Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  P. Spano,et al.  Attenuation of Excitatory Amino Acid Toxicity by Metabotropic Glutamate Receptor Agonists and Aniracetam in Primary Cultures of Cerebellar Granule Cells , 1993, Journal of neurochemistry.

[28]  T. Knöpfel,et al.  Metabotropic glutamate receptors: novel targets for drug development. , 1995, Journal of medicinal chemistry.

[29]  SR Glaum,et al.  Metabotropic glutamate receptors mediate excitatory transmission in the nucleus of the solitary tract , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[31]  G. Collingridge,et al.  Characterisation of LTP induced by the activation of glutamate metabotropic receptors in area CA1 of the hippocampus , 1993, Neuropharmacology.

[32]  C. Cotman,et al.  Rapid Communication: Ca2+ Channel Blockers Attenuate β‐Amyloid Peptide Toxicity to Cortical Neurons in Culture , 1994 .

[33]  D. Condorelli,et al.  Activation of Metabotropic Glutamate Receptors Prevents Neuronal Apoptosis in Culture , 1995, Journal of neurochemistry.

[34]  Li Chen,et al.  Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation , 1992, Nature.

[35]  H. Shinozaki,et al.  Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. , 1994, European journal of pharmacology.

[36]  D. Lovinger,et al.  Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: Subtype-specific coupling to ion channels , 1995, Neuron.

[37]  H. Sugiyama,et al.  The Expression of Two Splice Variants of Metabotropic Glutamate Receptor Subtype 5 in the Rat Brain and Neuronal Cells During Development , 1995, Journal of neurochemistry.

[38]  Serge Charpak,et al.  Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters , 1990, Nature.

[39]  A. Young,et al.  Anatomical Distribution of Metabotropic Glutamate Receptors in Mammalian Brain , 1994 .

[40]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[41]  P. Conn,et al.  Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1 , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  D. Condorelli,et al.  Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells , 1995, Neuropharmacology.

[43]  E. Aronica,et al.  Interaction between ß-N-methylamino- l-alanine and excitatory amino acid receptors in brain slices and neuronal cultures , 1991, Brain Research.

[44]  D. Winder,et al.  Regulation of Neuronal Circuits and Animal Behavior by Metabotropic Glutamate Receptors , 1994 .

[45]  J. Bockaert,et al.  The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  K. Maiese,et al.  Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats , 1995, Neuroscience Letters.

[47]  M. Miras-Portugal,et al.  Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation , 1992, Nature.

[48]  D. Schoepp,et al.  Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage , 1992, Neuroscience Letters.

[49]  O. Manzoni,et al.  Metabotropic Glutamate Receptors Inhibiting Excitatory Synapses in the CA1 Area of Rat Hippocampus , 1995, The European journal of neuroscience.

[50]  Peter L. Carlen,et al.  NMDA and quisqualate reduce a Ca-dependent K+ current by a protein kinase-mediated mechanism , 1990, Neuroscience Letters.

[51]  F. Nicoletti,et al.  Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. , 1995, Molecular pharmacology.